Drugs of Abuse Compliance Monitoring Pan
eD-H Order Code
LAB4103
Specimen Collection Information
Specimen | Minimum Test Volume | Container | Special Handling |
---|---|---|---|
Urine | 1.0 ML | chem |
Specimen Transport Temperature
Refrigerated
Specimen Stability
Additional Specimen Instructions
This testing panel includes
1. In house screens for amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, tricyclic antidepressants, ethanol and adulterants will be performed in the DHMC Chemistry Laboratory. Any presumptive positive result will automatically trigger a confirmation add on order that will be sent for confirmatory testing at an additional charge.
2. In addition, a quantitative opioid panel for the following 19 compounds will be performed via liquid chromatography tandem mass spectrometry in the DHMC Chemistry Laboratory: morphine, oxymorphone, hydromorphone, dihydrocodeine, naloxone, codeine, noroxycodone, oxycodone, 6-MAM, norhydrocodone, O-desmethyltramadol, hydrocodone, norfentanyl, tramadol, Norbuprenorphine, fentanyl, buprenorphine, EDDP+, and methadone.
This urine drugs of abuse screen WILL NOT detect the use of Methylphenidate(Ritalin/Concerta). To monitor compliance or serrupticious use, please order urine testing for Methylphenidate, eDH LAB3901.
Day(s) Performed
Urine Drug Screen:
Monday through Sunday; continuously
Urine Opioid Panel:
Varies.
2 runs done weekly (Monday through Friday)
CPT(s)
80364 ; 80307 ; 80307 ;
Performing Lab Section
Chemistry